Managing Complex Peripheral Nerve Injuries Within the Military Health System: A Multidisciplinary Approach to Treatment, Education, and Research at Walter Reed National Military Medical Center.
Mil Med. 2019 Nov 30;:
Addition of Cyclophosphamide "On Demand" to Lenalidomide and Corticosteroids in Patients With Relapsed/Refractory Multiple Myeloma-A Retrospective Review of a Single-center Experience.
Clin Lymphoma Myeloma Leuk. 2018 Dec 20;:
Ann Intern Med. 2019 Feb 05;:
J Oncol Pract. 2018 Jul;14(7):425-426
Final outcomes of escalated melphalan 280 mg/m2 with amifostine cytoprotection followed autologous hematopoietic stem cell transplantation for multiple myeloma: high CR and VGPR rates do not translate into improved survival.
Bone Marrow Transplant. 2018 Jun 15;:
Curr Oncol. 2017 Aug;24(4):e328-e332
Blood. 2017 Apr 13;129(15):2041-2042
Curr Hematol Malig Rep. 2017 Mar 20;:
Elotuzumab with lenalidomide and low-dose dexamethasone in patients with relapsed multiple myeloma: A randomized phase II study.
J Clin Oncol. 2011 May 20;29(15_suppl):8014
A retrospective chart review study of relapsed or refractory multiple myeloma (MM) patients (Pts): A look into historical treatment (Tx) patterns.
J Clin Oncol. 2009 May 20;27(15_suppl):e19535